Early Phase 1 DM Clinical Trials
7 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–7 of 7 trials
Recruiting
Early Phase 1
Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes
T1DM - Type 1 Diabetes Mellitus
Shanghai Zhongshan Hospital9 enrolled1 locationNCT07528105
Recruiting
Early Phase 1
A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus
T2DM
The First Affiliated Hospital of Henan University of Science and Technology9 enrolled1 locationNCT07347080
Recruiting
Early Phase 1
Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients
Diabetic Macular Edema (DME)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine32 enrolled2 locationsNCT07362927
Recruiting
Early Phase 1
Safety and Dystrophin Expression of SPOT-mRNA03 in Duchenne Muscular Dystrophy (DMD) Patients
Duchenne Muscular Dystrophy (DMD)
Shanghai Siponuoyin Biotechnology Co Ltd6 enrolled1 locationNCT07188012
Recruiting
Early Phase 1
Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy (DMD)
Shanghai Jiao Tong University School of Medicine12 enrolled1 locationNCT06900049
Recruiting
Early Phase 1
Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy (DMD)
Shanghai Jiao Tong University School of Medicine6 enrolled1 locationNCT06641895
Completed
Early Phase 1
Use of the Nutromics Sensor Device for the determination of Vancomycin concentrations and to evaluate biosensor safety.
Therapeutic Drug Monitoring (TDM)
Nutromics IP Pty Ltd27 enrolled1 locationACTRN12622000280707